Arq. Bras. Oftalmol.
Arquivos Brasileiros de Oftalmologia
Arq. Bras.
Oftalmol.
0004-2749
1678-2925
Objetivo:
Observar se há diferença nas funções visuais entre os prematuros com retinopatia
da prematuridade (ROP) pós-tratamento em relação aos prematuros com retinopatia da
prematuridade pós-regressão espontânea. E entre cada um destes grupos com o
controle sem ROP.
Métodos:
Estudo transversal, observacional, não cego. Incluídas crianças prematuras
nascidas entre 06/1992-06/2006 e examinadas entre 06/2009 e 12/2010; idade
gestacional menor ou igual a 32 semanas e peso ao nascimento menor ou igual a
1.599 g; cadastrados no banco de dados do Hospital de Olhos Sandalla Amin Ghanem;
com diagnóstico de retinopatia estágio II ou III em pelo menos um dos olhos com
regressão espontânea ou por tratamento da ROP e sem retinopatia da prematuridade;
mínimo de três consultas no período de seleção; máximo de seis meses de idade
cronológica para o primeiro exame no HOSAG; idade cronológica mínima de quatro
anos no período da reavaliação. Foram excluídas crianças prematuras que não
responderam ou não foram localizados para os exames de reavaliação; e que não
ofereciam condições de realização dos exames, por apresentarem comprometimento
severo do sistema nervoso central ou síndromes impeditivas. Os prematuros foram
divididos em três grupos: G1- prematuros com ROP pós-tratamento; G2- com ROP
pós-regressão espontânea; e G3- sem ROP. Função visual avaliada por meio da
acuidade visual (AV), teste de sensibilidade ao contrate (TSC), teste de cores
(TC), exame de motricidade ocular e estereopsia.
Resultados:
Foram examinados 24 prematuros (48 olhos). No grupo G1 formado por 7 prematuros;
G2, 8 prematuros e G3, 9 prematuros. AV normal: 64,28% (G1), 87,5% (G2) e 100%
(G3); TSC normal: 66,67% (G1), 100% (G2) e 55,56% (G3); TC de Ishihara normal,
100% (G1 e G2) e 86% (G3); TC de Farnsworth normal: 20% (G1), 75% (G2) e 50% (G3).
Estereopsia normal: 0,00% (G1), 25% (G2) e 3,5% (G3). Estrabismo: 37% (G2), 0,00%
(G1 e G3). A prevalente tendência de respostas abaixo do esperado no TSC e TC
entre os prematuros do grupo G3 exige novos estudos sobre o assunto em prematuros
com maior idade.
Conclusão:
As funções visuais não apresentaram diferença entre os três grupos de prematuros
estudados.
INTRODUCTION
For many decades, researchers worldwide have been investigating the causes of
retinopathy of prematurity (ROP) and the best method to identify the preterm children
that are at risk of developing this disease(19). In 2007, one ROP research group in Brazil published the
criteria for selecting premature children for examination and ROP treatment, following
the assessment of regional characteristics of the disease in Brazil(10).
At present, the analysis of the results of visual functions (VF) of premature infants,
i.e., visual acuity, chromatic and contrast discrimination, visual field, stereopsis,
and ocular motility, has contributed to unravel the influence of ROP and its treatment
on these functions. The effects of developmental conditions during the neonatal period
(ROP development, low birth weight, gestational weight and age above the expected for
ROP development, presence of neonatal complications, and brain damage) on visual
functions have not yet been elucidated(11-16).
The knowledge of the risk factors for VF among premature infants is important for the
selection of those who need to be followed up after the neonatal period.
This study aimed to determine possible differences in VF between premature infants at
ROP stages II and III and premature infants with spontaneous remission of ROP stages II
and III, and compare each of these groups with a group without ROP.
METHODS
This was an observational, nonblinded, crosssectional study of the VF responses of
premature infants registered in the database of the Hospital de Olhos Sadalla Amin
Ghanem (HOSAG). HOSAG database comprised children born before 36 weeks of gestation,
according to the definition of prematurity of the World Health
Organization(17). The
premature infants were selected from the Darcy Vargas Maternity, in Joinville, and from
other regions in the state of Santa Catarina, for followup after being discharged from
the institution where their delivery was conducted. They were classified and treated for
ROP according to the International Committees in force during the selection period
(06/1992 06/2006)(7-9). During the reevaluation period
(06/2009 12/2010), the infants who fulfilled the criteria of the study underwent eye
examinations at HOSAG. The following inclusion criteria were used: premature infants
born between 06/1992 and 06/2006, gestational age ≤32 weeks and birth weight ≤1,599 g,
absence of ROP, occurrence of ROP in stages II or III with spontaneous remission or
remission by cryotherapy or laser treatment in at least one eye, minimum of three
medical consultations during the selection period, maximum chronological age of 6 months
at the time of the first examination at HOSAG (selection period), and minimum
chronological age of 4 years during the reevaluation period. The exclusion criteria
were: infants who did not respond or were not followed up for the reevaluation tests,
and those who did not fulfill the criteria for VF assessment because of severe
impairment of the central nervous system or syndromes that hindered the performance of
the tests.
Infants were divided into three groups: G1, premature infants with ROP, stages II and
III, treated by laser or cryotherapy; G2, premature infants with ROP, stages II and III,
with spontaneous remission; and G3, premature infants without ROP (control).
RE-EVALUATION TESTS
Distance visual acuity (VA)
After appropriate optical correction, each eye was separately examined according to a
multiethnic pediatric eye disease study (MEPEDS) with preschool children, published
in 2009, in which VA better or equal to 20/30 Snellen (or 0.67 in decimal or 0.18 in
logMAR) was considered normal(18,19).
Infants with VA values lower than normal formed a distinct group and were used for
comparison purposes. The letter E on the Snellen chart was used for children aged
<7 years or illiterate, and letters of the alphabet were used for children aged
>7 years and literate. Each line had five letters (ETDRS table), and two mistakes
were tolerated for the last line visualized on the chart. Visual acuity was assessed
at a distance of 4 m. The optotypes were generated using the Opto Magis
2nd generation software and transmitted via a flat screen monitor
(Phillips) that complied with the specifications required by the software (1522inch
liquidcrystal display, backlighting of 200 cd/m2, and working distance of
3.09.5 m). The optotypes were configured by the system software according to the
distance used in the test. This system also provided the sensitivity contrast and the
Ishihara color tests.
The Teller VA cards test was exceptionally used. Children with neurological and
psychomotor development (NPMD) were excluded, particularly those with intellectual or
postural and motor stability impairments that precluded the performance of >2 of
the proposed tests.
Contrast sensitivity test (CST)
CST was separately performed on each eye. In this test, gray on white saturation
followed a 5% increment scale until 100% black was reached. Values of 5% - 10% were
considered normal (NL), values >10% were considered altered (ALT), and the NU
category comprised premature infants not submitted to the examination (for
statistical purposes). The test was performed at a distance of 4 m, in a dark room,
and the only light visible was that from the display. CST was assessed with the
optotypes placed two to three lines above the best visual acuity measured (e.g., in
VA 20/20, CST was assessed at 20/40).
An optimal contrast test for preschool children does not exist(20,21). This system was selected because the Opto Magis visual
acuity equipment allows this test to be applied in any optotype, which is appropriate
for use with children.
Farnsworth and Ishihara color tests
The Farnsworth D-15 test was performed with natural light and both eyes open.
Considering that the children examined were aged <12 years, large charts were used
(in subnormal vision) to facilitate the test. The software analyzed the results and
generated a graph with the score values.
The Ishihara color test was separately applied to each eye and was performed with the
child standing at a distance of 4 m in a dark room. The same software described above
generated a sequence of plates with a pattern of colored dots, so that the numbers on
each plate could be identified by people without chromatic visual impairments but
could not be distinguished by people with abnormal color vision. A total of 38 plates
were used, and among them, 13 exhibited a linear pattern that was appropriate for
illiterate children, and 25 had a numerical pattern (four of the latter were blind).
Children who had difficulty undergoing this test or did not recognize numbers were
tested using the Ishihara color test in a booklet format, wherein the plates were
shown from a 40cm distance. Children who did not recognize the numbers were asked to
follow with the finger the "little road" in a different color in the "pool of dots."
The children who performed the test without making mistakes were classified as normal
(NL), the children who did not perform the test or the test was not conclusive were
classified as NU, and the children unable to identify more than three numbers in the
Ishihara color test were classified as altered (ALT).
Static refraction (under cycloplegia)
In children aged <7 years, one drop of cyclopentolate 1% and one drop of
tropicamide 1% were instilled in each eye 30 min before the refraction test. In
children aged >7 years of age, one drop of tropicamide 1% was instilled in each
eye thrice, with an interval of 5 min, and the test was performed 30 min after
instillation of the first drop(22). Retinoscopy was performed with trial frame lenses and was
confirmed using a skiascopy rack. For statistical analysis, the spherical equivalent
was used both for myopia and hyperopia with astigmatism. The spherical equivalent
corresponded to the sum of the spherical degree and 50% of the value of astigmatism.
Astigmatism was considered significant when ≥1.50 negative diopters and the
percentage difference between the groups was calculated.
Motility test
Eye motility was assessed using the Hirschberg, Krimsky, and the eye cover ocular
tests, by observing fixation in the nine positions of gaze. Versions and ductions
were tested. The groups were compared for the presence or absence of strabismus.
Stereopsis
Stereoscopic assessment was performed using the Titmus test. The following
classification was used: normal (NL): 40 arcseconds, altered (ALT): >40
arcseconds, and NRT: those who were unable to perform the Titmus test. To facilitate
the calculation of the statistical difference, two distinct groups were considered:
the group of premature infants with normal stereopsis (40 arcseconds) and the group
with stereopsis above this value.
Binocular indirect ophthalmoscopy (BIO )
The BIO test was used for the assessment of the anatomical retinal appearance of
premature infants in the three groups. The test was filmed and recorded in DVD.
The pediatric ophthalmologist who performed the BIO, VA, CST, and color tests and the
orthoptist who performed the eye motility and stereopsis tests followed up the
children at HOSAG after the selection period.
STATISTICAL ANALYSIS
The Fisher's exact test was used to evaluate the association between the dichotomous
variables. The nonparametric MannWhitney test was used to compare the quantitative
variables between the groups. Values of p<0.05 indicated significance difference.
Data were analyzed using the Statistica software, version 8.0.
RESULTS
The HOSAG database (TASY) included 432 premature infants examined for the risk of
developing ROP during the selection period. More details are shown in table 1.
Table 1
Premature children selected and examined between 06/1992 and 06/2006 at HOSAG:
reasons for excluding subjects from the study on visual function
assessment
Motive of exclusion
Total number of premature children 432
% 100
Total number of premature children per study
24
6.0
Gestational weight and age above required
266
61.0
<3 visits during the selection period
39
9.0
Impossible to contact
22
5.0
Children aged <4 years on re-evaluation
11
2.5
Chronological age >6 months on first test
11
2.5
ROP stage higher or lower than required
11
2.5
Subnormal vision or severe neuropsychomotor impairment
9
2.0
Informed deaths
3
0.6
Children were followed up by another service
3
0.6
Other factors
33
7.6
Source: HOSAG records (2012).
ROP= retinopathy of prematurity; Other factors= did not agree to participate in
the study or withdrawal from the study.
Twenty-four premature infants were selected and divided into three groups: G17 premature
infants after ROP treatment; G28 premature infants after spontaneous ROP remission; and
G39 premature infants without ROP.
The results of the comparison between the groups with regard to VA, SCT, chromatic
sensitivity test, presence of strabismus, and stereopsis are shown in tables 2-7.
Table 2
Visual acuity Snellen test (OD and OS): Comparison between premature children
after ROP treatment (G1) and premature children after ROP remission (G2) and
between each group with ROP and the control group (G3)
Groups
N
Normal VA %
Low VA %
p value
G1 OD
7
71.43
28.57
0.569
G2 OD
8
87.50
12.50
G1 OS
7*
57.14
42.84
0.282
G2 OS
8
87.50
12.50
G1 OD
7
71.43
28.57
0.175
G3 OD
9
100.00
0.00
G1 OS
7*
57.14
42.84
0.282
G3 OS
9
100.00
0.00
G2 OD
8
87.50
12.50
0.471
G3 OD
9
100.00
0.00
G2 OS
8
87.50
12.50
0.471
G3 OS
9
100.00
0.00
Source: HOSAG records (2012).
OD= right eye; OS= left eye; VA= visual acuity;
*
= one premature child with amaurosis in the left eye after 6 years of age,
secondary to total late retinal detachment. Normal= visual acuity considered as
normal (20/30 or better).
Nonparametric Mann-Whitney test for p<0.05.
Table 3
Contrast sensitivity test (OD and OS): Comparison between premature infants
after ROP treatment (G1) and after ROP remission (G2) and between each group with
ROP and the control group (G3)
Groups
N
NL TSC %
ALT TSC %
p value
G1 OD
6*
66.67
33.33
0.192
G2 OD
7***
100.00
0.00
G1 OS
5**
60.00
40.00
0.523
G2 OS
7***
85.71
14.29
G1 OD
6
66.67
33.33
1
G3 OD
9
55.56
44.44
G1 OS
5
60.00
40.00
1
G3 OS
9
55.56
44.44
G2 OD
7
100.00
0.00
0.088
G3 OD
9
55.56
44.44
G2 OS
7
85.71
14.29
0.308
G3 OS
9
55.56
44.44
Source: HOSAG records (2012).
OD= right eye; OS= left eye; NL TSC= normal contrast sensitivity test; ALT TSC=
altered contrast sensitivity test;
G1(*): one premature infant in G1 did not undergo the test on both eyes;
1 (**): another premature infant in G1 did not undergo the CST test on the left
eye (total retinal detachment);
G2 (***): one premature infant in G2 did not undergo the CST test.
Nonparametric Mann-Whitney test for p<0.05.
Table 4
Ishihara color test: comparison between groups G1 and G3 (OU) and G2 and G3
(OU)
Groups
N
CT IHNL %
CT IHALT %
p value
G1 OU
5
100.00
0.00
1
G3 OU
7
85.71
14.29
G2 OU
6
100.00
0.00
1
G3 OS
7
85.71
14.29
Source: HOSAg records (2012).
OU= both eyes; OS= left eye; CT IHNL= normal Ishihara color test; CT IHALT=
altered Ishihara color test; N= number of premature infants who underwent the
test in each group (total premature infants per group: G1=7, G2=8, and
G3=9).
Nonparametric Mann-Whitney test for p<0.05.
Table 5
Farnsworth D-15 AO color test: comparison between groups G1 and G2
Groups
N
CT FW-D15 NL %
CT FW-D15 ALT %
p value
G1 OU
5
20.00
80.00
0.206
G2 OU
4
75.00
25.00
G1 OU
5
20.00
80.00
0.524
G3 OU
4
50.00
50.00
G2 OU
4
75.00
25.00
1
G3 OU
4
50.00
50.00
Source: HOSAG records (2012).
OU= both eyes; CT FW-D15 NL= normal Farnsworth D-15 color test; CT FW-D15 ALT=
altered Farnsworth D-15 color test. N= number of premature infants that
underwent the test in each group (total premature infants per group: G1=7,
G2=8, G3=9).
Nonparametric Mann-Whitney test for p<0.05.
Table 6
Strabismus: Comparison between premature infants after ROP treatment (G1) and
after remission of ROP Stages II and III (G2)
Groups
N
Strabismus Yes (%)
Strabismus No (%)
p value
G1 OU
7
0.00
100.00
0.200
G2 OU
8
37.50
62.50
G1 OU
7
0.00
100.00
-
G3 OU
9
0.00
100.00
G2 OU
8
37.50
62.50
0.082
G3 OU
9
0.00
100.00
Source: HOSAG records (2012).
OU= both eyes.
Nonparametric Mann-Whitney test for p<0,05.
Table 7
Stereopsis: Comparison between premature infants with after treatment RO (G1)
and after remission of ROP Stages II and III (G2)
Groups
N
Stereopsis NL (%)
Stereopsis ALT (%)
p value
G1 OU
7
0.00
100.00
p: 0.467
G2 OU
8
25.00
75.00
G1 OU
7
0.00
100.00
p: 0.200
G3 OU*
8
37.50
62.50
G2 OU
8
25.00
75.00
P:1
G3 OU
8
37.50
62.50
Source: HOSAG records (2012).
OU= both eyes; NL= normal Titmus test; ALT= altered, >40 arcseconds; NRT=
those who were unable to perform the Titmus test.
*
= one premature infant did not undergo the Titmus test.
Nonparametric Mann-Whitney test for p<0.05.
Demographic data and the refraction test and indirect ophthalmoscopy data are shown in
tables 1 and 2.
DISCUSSION
Weight at birth and gestational age above those required to participate in the study
were the most important factors for excluding premature infants from the study (Table 1). This reflects the comprehensive approach
to the management of ROP in Brazil until the publication of the guidelines for treating
ROP in the country, in 2007(9). This study was the result of several meetings of the ROP group
in Brazil, where studies from various regions of the country were analyzed and
discussed(23). Outside
Brazil, the definition of the limits of weight and gestational age that indicate risk of
ROP and blindness was established by the 1984 and 1987 International
Committees(7,8). Other authors observed that the lack
of cooperation in answering the repeated calls to participate in the visual assessment
tests after the selection period was the factor that most contributed to the cohort
reduction (176/505 premature infants)(15). In the present study, this factor was included in the result
specified as "other factors" and represented <10% of the reduction (Table 1).
The good visual functions (FV) results obtained for group G1 were not in line with the
findings of a study on VA and strabismus in preschool children published in 1999,
wherein the authors observed worse VA among premature infants after ROP
treatment(24). Other
authors have indicated low birth weight and ROP (mainly stages III and IV) negatively
affect the response to VA, static refraction, chromatic and contrast sensitivity
tests(13-15).
VA was slightly better in group G2, considering that ROP, gestational age, birth weight,
and age group at the time of the re-evaluation examination were similar among groups
(Table 2). The high frequency of normal VA
among premature infants with postremission ROP and those without ROP was also observed
by other researchers(15).
Previous studies suggested that the exclusion of premature infants with neuropsychomotor
development problems and the type of treatment performed led to better visual acuity
even in premature infants after ROP treatment. Moreover, ROP laser treatment had a
positive effect on these results(24-26). In the
present study, only one premature infant in group G1 underwent cryotherapy; this fact
and the exclusion of premature infants with severe development impairment may have
contributed to good VA performance in the three groups under study.
With regard to contrast visual sensitivity, the group of premature infants after ROP
treatment exhibited lower contrast sensitivity than the remaining groups (Table 3). On the other hand, in 2001 the
Cryotherapy for ROP Cooperative Group observed a better contrast sensitivity among
treated premature infants(20). The difficulty in correlating low contrast sensitivity with
ROP severity was also observed by other authors(15,21).
The result obtained for group G2 was slightly better than that obtained for group G3
(without ROP). This unexpected finding may be explained by the early age of the
premature children in group G3 (mean age of 5 years, whereas the mean age of the
remaining groups was 6 years), and was not in line with the findings of the Cryotherapy
for ROP Cooperative Group, who studied 10yearold children in 2001. According to a 1981
study conducted with preschool children and their mothers, the factor that affected the
responses was the difference in associative knowledge and not necessarily the age
difference between the two groups(27).
In group G1, the different CST results obtained for the right and left eyes may be
explained by the difference in disease severity between the eyes.
Other reasons for excluding G1 and G2 groups from the test were the difficulty in
communicating verbally, overall developmental and learning disability (inability to
understand the test), and total retinal detachment in one eye (Table 3).
The three groups under study exhibited good performance in the Ishihara color test
(Table 4). However, there was a large
percentage of unfavorable responses in G1 using the Farnsworth D-15 test. This
percentage was significantly higher than that observed by the CRYO-ROP study group (80%
in G1 vs. 2.8% in the CRYO-ROP study). According to these authors, this deficiency was
related to low visual acuity and not to possible alterations inherent to prematurity
itself or to ROP severity(28). However, in the present study, 64.28% premature infants in
group G1 exhibited good visual acuity.
Chart 1
Demographic data for the three groups of premature preschool children
classified into three groups of retinopathy of prematurity (G1, G2, and G3),
considering the variables gender, chronological age on re-evaluation (CRA),
gestational age (GA), birth weight (BW), and number of medical consultations
between the selection and re-evaluation periods
Groups
Gender
CRA (years)
GA (weeks)
WB (grams)
Number of Visits
N
M (%)
F (%)
mean
DP
mean
DP
mean
DP
mean
DP
G 1
7
71
29
6.1
1.6
28.1
1.9
1.015
123.5
24.4
20.5
G 2
8
25
75
6.5
1.9
27.2
1.6
963.7
123.0
19.8
13.9
G 3
9
78
22
5.1
0.9
28.4
2.5
991.1
258.4
9.7
4.2
G1= group after treatment of ROP stages II and III; G2= groups at ROP stages II
and III in remission; G3= group without ROP; M= male; F= female; CRA=
chronological age on re-evaluation; GA= gestational age; BW= birth weight. SD=
standard deviation; N= total number.
Chart 2
Distribution of static refraction and vA data in groups G1, G2, and G3
Right eye
Left eye
Spherical
Cylinder
Axis
Acuity
Spherical
Cylinder
Axis
Acuity
G1- laser
1
+0.50
-0.50
180
20/20
0.00
-0.50
180
20/20
2
+2.00
0.00
0
20/20
+1.50
0.00
0
20/30
3
-5.50
-3.00
105
20/30
-4.25
0.00
0
20/25
4
-4.25
-0.75
125
20/60
0.00
0.00
0
20/20
5
+0.50
-1.75
180
20/30
-0.50
-3.00
180
20/40
6
-6.50
-2.00
170
20/30
*
**
7
-2.75
-0.50
180
20/63
-2.75
-0.50
180
20/63
G2- without laser
8
+4.50
-1.25
10
20/20
+4.75
-1.50
170
20/20
9
+2.25
0.00
0
20/20
+2.50
0.00
0
20/20
10
+2.00
-0.50
165
20/20
+2.25
0.00
0
20/20
11
+2.00
-0.50
180
20/20
+2.00
-0.50
165
20/20
12
+0.25
-0.25
90
20/20
+0.25
0.00
0
20/20
13
+1.50
-0.25
90
20/20
+1.50
-0.25
5
20/20
14
+1.75
-1.25
15
20/50
+1.75
-1.50
180
20/50
15
+2.00
-0.50
90
20/20
+1.50
0.00
0
20/20
G3- without ROP
16
-0.25
0.00
0
20/20
0.00
0.00
0
20/20
17
+2.50
0.00
0
20/20
+2.50
0.00
0
20/20
18
+1.50
-0.75
180
20/20
+1.50
-1.00
180
20/20
19
+1.00
-0.50
180
20/20
+1.00
-0.50
180
20/20
20
+1.75
0.00
0
20/20
+2.00
-0.50
180
20/20
21
+3.00
-0.25
90
20/20
+2.50
0.00
0
20/20
22
+1.50
0.00
0
20/20
+1.50
-0.50
90
20/20
23
+1.00
0.00
0
20/20
+1.00
0.00
0
20/20
24
+1.25
-0.50
170
20/20
+1.50
0.00
0
20/20
G1= after treatment ROP stages II and III; G2= ROP stages II and III in
remission; G3= without ROP;
*
= refraction impossible, total retinal detachment;
**
= amaurosis.
In the three groups under study, the reason for excluding premature infants from this
test was their difficulty in understanding the color test (TC), which was in agreement
with the findings of other authors who observed that, after excluding the children
unable to perform the color test, the responses of premature children were very similar
to those of full-term children(29).
The absence of cases of strabismus in group G1 contradicted the findings of other
authors in similar studies, which indicated the occurrence of strabismus in 26%-44% of
premature infants after ROP treatment, and this proportion was dependent on the type of
treatment (laser or cryotherapy)(14,24,25,30). In the present study, the study sample was small and the
possibility that the exclusion criteria selected premature infants without strabismus in
group G1 cannot be discarded. The ideal would be to assess the presence of strabismus in
premature children excluded for other reasons; however, such evaluation was not the aim
of this study.
A 37% incidence of convergent strabismus in group G2 was in accordance with the results
obtained by other authors, who found a similar frequency and a higher percentage of
convergent strabismus among premature infants after spontaneous ROP
remission(24,31).
Of the four infants in G2 with neuropsychomotor development problems, three presented
with strabismus. Therefore, the proportion of infants with neurological problems was
relevant in this group and may explain the higher percentage of strabismus in the group
with spontaneous remission, as was also observed by other authors(11,14,24,30,31).
Stereopsis was present in 57% the premature infants in group G1. A similar result was
observed in a study published in 2005, wherein 66.6% premature infants with ROP treated
with laser exhibited stereopsis(24).
However, no premature infants exhibited normal stereopsis. Strabismus was not among the
causes of the low performance of G1 with regard to stereopsis. On the other hand, low
unilateral or bilateral VA was responsible for this result. The lower stereoscopic
resolution observed among premature infants after ROP treatment was in line with other
studies that associated stereoscopic resolution with ROP severity(14,30). In group G2, the nonrecognition of the Titmus test and the
suppression caused by strabismus represented 37% of the 75% change in this test. In
addition, age contributed to the low frequency of normal stereopsis among the groups G2
and G3.
In this study there was no difference between premature children after ROP treatment and
those after spontaneous ROP remission with regard to the visual functions assessed. In
addition, there was no difference between the groups with ROP and the control (Tables 2-7).
The limitations of the present study include sample size, which may have contributed to
the nonsignificant differences between the groups. Therefore, additional studies from
other institutions that study ROP in Brazil are necessary.
The lack of standardization of the chromatic and contrast sensitivity tests precludes
the comparison of results across studies. Further studies using tests performed in
computers and highdefinition monitors may help solve these limitations.
The results of VA and the presence of strabismus in the groups with ROP highlight the
risks of low vision and amblyopia and suggest the need for close followup of preschool
and school children.
CONCLUSION
There was no significant difference in visual functions between premature infants after
ROP treatment and those after spontaneous remission, and between premature infants with
ROP and without ROP.
Funding: No specific financial support was available for this study.
Study carried out at Hospital de Olhos Sadalla Amin Ghanem, Joinville - Santa
Catarina (SC), Brazil.
Projeto aprovado pelo CEP do Hospital São José, Joinville - S/C.
REFERENCES
1
1. Terry TL. Extreme prematurity and fibroblastic overgrowth of
persistent vascular sheath behind each crystalline lens. Am J Ophthalmol.
1942;25:203-4.
Terry
TL
Extreme prematurity and fibroblastic overgrowth of
persistent vascular sheath behind each crystalline lens
Am J Ophthalmol
1942
25
203
204
2
2. Owens WC, Owens EU. Retrolental fibroplasia in premature infants. Am
J Ophthalmol. 1949;32(1):1-21.
Owens
WC
Owens
EU
Retrolental fibroplasia in premature
infants
Am J Ophthalmol
1949
32
1
1
21
3
3. Reese AB. Persistence and hyperplasia of primary vitreous;
retrolental fibroplasia; two entities. Arch Ophthal.
1949;41(5):527-52.
Reese
AB
Persistence and hyperplasia of primary vitreous;
retrolental fibroplasia; two entities
Arch Ophthal
1949
41
5
527
552
4
4. Kinsey VE. Retrolental fibroplasia; cooperative study of retrolental
fibroplasia and the use of oxygen. AMA Arch Ophthalmol.
1956;56(4):481-543.
Kinsey
VE
Retrolental fibroplasia; cooperative study of
retrolental fibroplasia and the use of oxygen
AMA Arch Ophthalmol
1956
56
4
481
543
5
5. Kinsey VE, Arnold HJ, Kalina RE, Stern L, Stahlman M, Odell G, et al.
PaO2 levels and retrolental fibroplasia: a report of the cooperative study.
Pediatrics. 1977;60(5):655-68.
Kinsey
VE
Arnold
HJ
Kalina
RE
Stern
L
Stahlman
M
Odell
G
et al
PaO2 levels and retrolental fibroplasia: a report of the
cooperative study
Pediatrics
1977
60
5
655
668
6
6. Flynn JT, Bancalari E, Bachynski BN, Buckley EB, Bawol R, Goldberg R,
et al. Retinopathy of prematurity. Diagnosis, severity, and natural history.
Ophthalmology. 1987;94(6): 620-9.
Flynn
JT
Bancalari
E
Bachynski
BN
Buckley
EB
Bawol
R
Goldberg
R
et al
Retinopathy of prematurity. Diagnosis, severity, and
natural history
Ophthalmology
1987
94
6
620
629
7
7. An international classification of retinopathy of prematurity. The
Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol.
1984;102(8):1130-4.
An international classification of retinopathy of
prematurity. The Committee for the Classification of Retinopathy of
Prematurity
Arch Ophthalmol
1984
102
8
1130
1134
8
8. An international classification of retinopathy of prematurity. II.
The classification of retinal detachment. The International Committee for the
Classification of the Late Stages of Retinopathy of Prematurity. Arch Ophthalmol.
1987;105(7):906-12. Erratum in: Arch Ophthalmol 1987;105(11):1498.
An international classification of retinopathy of
prematurity. II. The classification of retinal detachment. The International
Committee for the Classification of the Late Stages of Retinopathy of
Prematurity
Arch Ophthalmol
1987
105
7
906
912
Erratum in: Arch Ophthalmol 1987;105(11):1498
9
9. International Committee for the Classification of Retinopathy of
Prematurity. The International Classification of Retinopathy of Prematurity
revisited. Arch Ophthalmol. 2005;123(7):991-9. Review.
International Committee for the Classification of Retinopathy of
Prematurity
The International Classification of Retinopathy of
Prematurity revisited
Arch Ophthalmol
2005
123
7
991
999
Review
10
10. Zin A, Florêncio T, Fortes Filho JB, Nakanami CR, Gianini N,
Graziano RM, Moraes N; Brazilian Society of Pediatrics, Brazilian Council of
Ophthalmology and Brazilian Society of Pediatric Ophthalmology. [Brazilian guidelines
proposal for screening and treatment of retinopathy of prematurity (ROP) ]. Arq Bras
Oftalmol. 2007;70(5):875-83. Portuguese.
Zin
A
Florêncio
T
Fortes
JB
Filho
Nakanami
CR
Gianini
N
Graziano
RM
Moraes
N
Brazilian Society of Pediatrics
Brazilian Council of Ophthalmology and Brazilian Society of Pediatric
Ophthalmology
Brazilian guidelines proposal for screening and treatment
of retinopathy of prematurity
Arq Bras Oftalmol
2007
70
5
875
883
Portuguese
11
11. Holmström G, Larsson E. Longterm followup of visual functions in
prematurely born childrena prospective populationbased study up to 10 years of age. J
AAPOS. 2008;12(2):157-62.
Holmström
G
Larsson
E
Longterm followup of visual functions in prematurely
born childrena prospective populationbased study up to 10 years of
age
J AAPOS
2008
12
2
157
162
12
12. Mirabella G, Kjaer PK, Norcia AM, Good WV, Madan A. Visual
development in very low birth weight infants. Pediatr Res.
2006;60(4):435-9.
Mirabella
G
Kjaer
PK
Norcia
AM
Good
WV
Madan
A
Visual development in very low birth weight
infants
Pediatr Res
2006
60
4
435
439
13
13. O'Connor AR, Stephenson TJ, Johnson A, Tobin MJ, Ratib S, Moseley M,
et al. Visual function in low birthweight children. Br J Ophthalmol.
2004;88(9):1149-53.
O'Connor
AR
Stephenson
TJ
Johnson
A
Tobin
MJ
Ratib
S
Moseley
M
Visual function in low birthweight
children
Br J Ophthalmol
2004
88
9
1149
1153
14
14. O'Connor AR, Fielder AR. Visual outcomes and perinatal adversity.
Semin Fetal Neonatal Med. 2007;12(5):408-14.
O'Connor
AR
Fielder
AR
Visual outcomes and perinatal adversity
Semin Fetal Neonatal Med
2007
12
5
408
414
15
15. O'Connor AR, Stephenson T, Johnson A, Tobin MJ, Moseley MJ, Ratib S,
et al. Longterm ophthalmic outcome of low birth weight children with and without
retinopathy of prematurity. Pediatrics. 2002;109(1):12-8.
O'Connor
AR
Stephenson
T
Johnson
A
Tobin
MJ
Moseley
MJ
Ratib
S
Longterm ophthalmic outcome of low birth weight children
with and without retinopathy of prematurity
Pediatrics
2002
109
1
12
18
16
16. Robaei D, Kifley A, Gole GA, Mitchell P. The impact of modest
prematurity on visual function at age 6 years: findings from a populationbased study.
Arch Ophthalmol. 2006;124(6):871-7.
Robaei
D
Kifley
A
Gole
GA
Mitchell
P
The impact of modest prematurity on visual function at
age 6 years: findings from a populationbased study
Arch Ophthalmol
2006
124
6
871
877
17
17. World Health Organization. Weekly epidemiological record relevé
épidémiologique hebdomaire. Wkly Epidem Rec. 1984;59:205-12.
World Health Organization
Weekly epidemiological record relevé épidémiologique
hebdomaire
Wkly Epidem Rec
1984
59
205
212
18
18. Pan Y, TarczyHornoch K, Cotter SA, Wen G, Borchert MS, Azen SP,
Varma R; MultiEthnic Pediatric Eye Disease Study Group. Visual acuity norms in
preschool children: the MultiEthnic Pediatric Eye Disease Study. Optom Vis Sci.
2009;86(6):607-12.
Pan
Y
TarczyHornoch
K
Cotter
SA
Wen
G
Borchert
MS
Azen
SP
Varma
R
MultiEthnic Pediatric Eye Disease Study Group
Visual acuity norms in preschool children: the
MultiEthnic Pediatric Eye Disease Study
Optom Vis Sci
2009
86
6
607
612
19
19. Holladay J. Proper method for calculating average visual acuity. J
Refract Surg. 1997;13:388-91.
Holladay
J
Proper method for calculating average visual
acuity
J Refract Surg
1997
13
388
391
20
20. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Contrast sensitivity at age 10 years in children who had threshold retinopathy of
prematurity. Arch Ophthalmol. 2001;119(8):1129-33.
Cryotherapy for Retinopathy of Prematurity Cooperative Group
Contrast sensitivity at age 10 years in children who had
threshold retinopathy of prematurity
Arch Ophthalmol
2001
119
8
1129
1133
21
21. Larsson E, Rydberg A, Holmström G. Contrast sensitivity in 10 year
old preterm and full term children: a population based study. Br J Ophthalmol.
2006;90(1):87-90.
Larsson
E
Rydberg
A
Holmström
G
Contrast sensitivity in 10 year old preterm and full
term children: a population based study
Br J Ophthalmol
2006
90
1
87
90
22
22. Bicas HE. Sociedade Brasileira de Oftalmologia Pediátrica.
Prescrição de óculos na infância [Internet]. São Paulo: Sociedade Brasileira de
Oftalmologia Pediátrica; s.d. p. 1-21. [citado 2014 Jan 17]. Disponível em:
http://www.cbo.com.br/cbo/sociedades/pediatria/artigos/prescricoes_oculos_infancia.pdf
Bicas
HE
Sociedade Brasileira de Oftalmologia Pediátrica
Prescrição de óculos na infância [Internet]
São Paulo
Sociedade Brasileira de Oftalmologia Pediátrica
s.d.
1
21
citado 2014 Jan 17
Disponível em: http://www.cbo.com.br/cbo/sociedades/pediatria/artigos/prescricoes_oculos_infancia.pdf
23
23. Sociedade Brasileira de Oftalmologia Pediátrica. Projeto ROP Brasil:
na prevenção da cegueira por retinopatia da prematuridade [Internet]. São Paulo:CBO;
2006. [citado 2014 Jan 17]. Disponível em:
http://dnanet.dna.com.br/sbop/site/interna.
asp?campo=119&secao_id=6
Sociedade Brasileira de Oftalmologia Pediátrica
Projeto ROP Brasil: na prevenção da cegueira por retinopatia da
prematuridade [Internet]
São Paulo
CBO
2006
citado 2014 Jan 17
Disponível em: http://dnanet.dna.com.br/sbop/site/interna.
asp?campo=119&secao_id=6
24
24. Holmström G, el Azazi M, Kugelberg U. Ophthalmological follow up of
preterm infants: a population based, prospective study of visual acuity and
strabismus. Br J Ophthalmol. 1999;83(2):143-50.
Holmström
G
el Azazi
M
Kugelberg
U
Ophthalmological follow up of preterm infants: a
population based, prospective study of visual acuity and
strabismus
Br J Ophthalmol
1999
83
2
143
150
25
25. Ospina LH, Lyons CJ, Matsuba C, Jan J, McCormick AQ. Argon laser
photocoagulation for retinopathy of prematurity: longterm outcome. Eye (Lond).
2005;19(11):1213-8.
Ospina
LH
Lyons
CJ
Matsuba
C
Jan
J
McCormick
AQ
Argon laser photocoagulation for retinopathy of
prematurity: longterm outcome
Eye (Lond)
2005
19
11
1213
1218
26
26. Sahni J, Subhedar NV, Clark D. Treated threshold stage 3 versus
spontaneously regressed subthreshold stage 3 retinopathy of prematurity: a study of
motility, refractive, and anatomical outcomes at 6 months and 36 months. Br J
Ophthalmol. 2005;89(2):154-9.
Sahni
J
Subhedar
NV
Clark
D
Treated threshold stage 3 versus spontaneously regressed
subthreshold stage 3 retinopathy of prematurity: a study of motility, refractive,
and anatomical outcomes at 6 months and 36 months
Br J Ophthalmol
2005
89
2
154
159
27
27. Atkinson J, French J, Braddick O. Contrast sensitivity function of
preschool children. Br J Ophthalmol. 1981;65(8):525-9.
Atkinson
J
French
J
Braddick
O
Contrast sensitivity function of preschool
children
Br J Ophthalmol
1981
65
8
525
529
28
28. Dobson V, Quinn GE, Abramov I, Hardy RJ, Tung B, Siatkowski RM, et
al. Color vision measured with pseudoisochromatic plates at fiveandahalf years in
eyes of children from the CRYOROP study. Invest Ophthalmol Vis Sci.
1996;37(12):2467-74.
Dobson
V
Quinn
GE
Abramov
I
Hardy
RJ
Tung
B
Siatkowski
RM
et al
Color vision measured with pseudoisochromatic plates at
fiveandahalf years in eyes of children from the CRYOROP study
Invest Ophthalmol Vis Sci
1996
37
12
2467
2474
29
29. Jackson TL, Ong GL, McIndoe MA, Ripley LG. Monocular chromatic
contrast threshold and achromatic contrast sensitivity in children born prematurely.
Am J Ophthalmol. 2003;136(4):710-9.
Jackson
TL
Ong
GL
McIndoe
MA
Ripley
LG
Monocular chromatic contrast threshold and achromatic
contrast sensitivity in children born prematurely
Am J Ophthalmol
2003
136
4
710
719
30
30. VanderVeen DK, Coats DK, Dobson V, Fredrick D, Gordon RA, Hardy RJ,
Neely DE, Palmer EA, Steidl SM, Tung B, Good WV; Early Treatment for Retinopathy of
Prematurity Cooperative Group. Prevalence and course of strabismus in the first year
of life for infants with prethreshold retinopathy of prematurity: findings from the
Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol.
2006;124(6):766-73.
VanderVeen
DK
Coats
DK
Dobson
V
Fredrick
D
Gordon
RA
Hardy
RJ
Neely
DE
Palmer
EA
Steidl
SM
Tung
B
Good
WV
Early Treatment for Retinopathy of Prematurity Cooperative Group
Prevalence and course of strabismus in the first year of
life for infants with prethreshold retinopathy of prematurity: findings from the
Early Treatment for Retinopathy of Prematurity study
Arch Ophthalmol
2006
124
6
766
773
31
31. Bremer DL, Palmer EA, Fellows RR, Baker JD, Hardy RJ, Tung B, et al.
Strabismus in premature infants in the first year of life. Cryotherapy for
Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol.
1998;116(3):329-33.
Bremer
DL
Palmer
EA
Fellows
RR
Baker
JD
Hardy
RJ
Tung
B
et al
Strabismus in premature infants in the first year of
life. Cryotherapy for Retinopathy of Prematurity Cooperative Group
Arch Ophthalmol
1998
116
3
329
333
Hospital de Olhos Sadalla Amin Ghanem; UTI Neonatal
da UNIMED, Joinville, Santa Catarina, (SC), BrazilHospital de Olhos Sadalla Amin GhanemBrazilCatarina, SC, BrazilHospital de Olhos Sadalla Amin Ghanem; UTI Neonatal
da UNIMED, Joinville, Santa Catarina, (SC), Brazil
UNIMED, UTI NeonatalUNIMEDUNIMED, UTI Neonatal
Ana Tereza Ramos Moreira
Universidade Federal do Paraná, PR, Brazil;
Hospital de Olhos do Paraná, Curitiba (PR), BrazilUniversidade Federal do ParanáBrazilCuritiba, PR, BrazilUniversidade Federal do Paraná, PR, Brazil;
Hospital de Olhos do Paraná, Curitiba (PR), Brazil
Hospital de Olhos do Paraná, Curitiba, PR, BrazilHospital de Olhos do ParanáBrazilCuritiba, PR, BrazilHospital de Olhos do Paraná, Curitiba, PR, Brazil
Silvia Chuffi
Hospital de Olhos Sadalla Amin Ghanem, Joinville,
Santa Catarina (SC), BrazilHospital de Olhos Sadalla Amin GhanemBrazilJoinville, Santa Catarina (SC), BrazilHospital de Olhos Sadalla Amin Ghanem, Joinville,
Santa Catarina (SC), Brazil
Susana Maria Bittencourt Sckudlarek
Hospital de Olhos Sadalla Amin Ghanem, Joinville,
Santa Catarina (SC), BrazilHospital de Olhos Sadalla Amin GhanemBrazilJoinville, Santa Catarina (SC), BrazilHospital de Olhos Sadalla Amin Ghanem, Joinville,
Santa Catarina (SC), Brazil
Disclosure of potential conflicts of interest: L.B. Bonotto, None;
A.T.R. Moreira, None; S. Chuffi, None; S.M.B. Sckudlarek, None.
SCIMAGO INSTITUTIONS RANKINGS
Hospital de Olhos Sadalla Amin Ghanem; UTI Neonatal
da UNIMED, Joinville, Santa Catarina, (SC), BrazilHospital de Olhos Sadalla Amin GhanemBrazilCatarina, SC, BrazilHospital de Olhos Sadalla Amin Ghanem; UTI Neonatal
da UNIMED, Joinville, Santa Catarina, (SC), Brazil
UNIMED, UTI NeonatalUNIMEDUNIMED, UTI Neonatal
Universidade Federal do Paraná, PR, Brazil;
Hospital de Olhos do Paraná, Curitiba (PR), BrazilUniversidade Federal do ParanáBrazilCuritiba, PR, BrazilUniversidade Federal do Paraná, PR, Brazil;
Hospital de Olhos do Paraná, Curitiba (PR), Brazil
Hospital de Olhos do Paraná, Curitiba, PR, BrazilHospital de Olhos do ParanáBrazilCuritiba, PR, BrazilHospital de Olhos do Paraná, Curitiba, PR, Brazil
Hospital de Olhos Sadalla Amin Ghanem, Joinville,
Santa Catarina (SC), BrazilHospital de Olhos Sadalla Amin GhanemBrazilJoinville, Santa Catarina (SC), BrazilHospital de Olhos Sadalla Amin Ghanem, Joinville,
Santa Catarina (SC), Brazil
Table 1
Premature children selected and examined between 06/1992 and 06/2006 at HOSAG:
reasons for excluding subjects from the study on visual function
assessment
Table 2
Visual acuity Snellen test (OD and OS): Comparison between premature children
after ROP treatment (G1) and premature children after ROP remission (G2) and
between each group with ROP and the control group (G3)
Table 3
Contrast sensitivity test (OD and OS): Comparison between premature infants
after ROP treatment (G1) and after ROP remission (G2) and between each group with
ROP and the control group (G3)
Chart 1
Demographic data for the three groups of premature preschool children
classified into three groups of retinopathy of prematurity (G1, G2, and G3),
considering the variables gender, chronological age on re-evaluation (CRA),
gestational age (GA), birth weight (BW), and number of medical consultations
between the selection and re-evaluation periods
Chart 2
Distribution of static refraction and vA data in groups G1, G2, and G3
table_chartTable 1
Premature children selected and examined between 06/1992 and 06/2006 at HOSAG:
reasons for excluding subjects from the study on visual function
assessment
Motive of exclusion
Total number of premature children 432
% 100
Total number of premature children per study
24
6.0
Gestational weight and age above required
266
61.0
<3 visits during the selection period
39
9.0
Impossible to contact
22
5.0
Children aged <4 years on re-evaluation
11
2.5
Chronological age >6 months on first test
11
2.5
ROP stage higher or lower than required
11
2.5
Subnormal vision or severe neuropsychomotor impairment
9
2.0
Informed deaths
3
0.6
Children were followed up by another service
3
0.6
Other factors
33
7.6
table_chartTable 2
Visual acuity Snellen test (OD and OS): Comparison between premature children
after ROP treatment (G1) and premature children after ROP remission (G2) and
between each group with ROP and the control group (G3)
Groups
N
Normal VA %
Low VA %
p value
G1 OD
7
71.43
28.57
0.569
G2 OD
8
87.50
12.50
G1 OS
7**
= one premature child with amaurosis in the left eye after 6 years of age,
secondary to total late retinal detachment. Normal= visual acuity considered as
normal (20/30 or better).
57.14
42.84
0.282
G2 OS
8
87.50
12.50
G1 OD
7
71.43
28.57
0.175
G3 OD
9
100.00
0.00
G1 OS
7**
= one premature child with amaurosis in the left eye after 6 years of age,
secondary to total late retinal detachment. Normal= visual acuity considered as
normal (20/30 or better).
57.14
42.84
0.282
G3 OS
9
100.00
0.00
G2 OD
8
87.50
12.50
0.471
G3 OD
9
100.00
0.00
G2 OS
8
87.50
12.50
0.471
G3 OS
9
100.00
0.00
table_chartTable 3
Contrast sensitivity test (OD and OS): Comparison between premature infants
after ROP treatment (G1) and after ROP remission (G2) and between each group with
ROP and the control group (G3)
Groups
N
NL TSC %
ALT TSC %
p value
G1 OD
6*
G1(*): one premature infant in G1 did not undergo the test on both eyes;
66.67
33.33
0.192
G2 OD
7***
G2 (***): one premature infant in G2 did not undergo the CST test.
100.00
0.00
G1 OS
5**
1 (**): another premature infant in G1 did not undergo the CST test on the left
eye (total retinal detachment);
60.00
40.00
0.523
G2 OS
7***
G2 (***): one premature infant in G2 did not undergo the CST test.
85.71
14.29
G1 OD
6
66.67
33.33
1
G3 OD
9
55.56
44.44
G1 OS
5
60.00
40.00
1
G3 OS
9
55.56
44.44
G2 OD
7
100.00
0.00
0.088
G3 OD
9
55.56
44.44
G2 OS
7
85.71
14.29
0.308
G3 OS
9
55.56
44.44
table_chartTable 4
Ishihara color test: comparison between groups G1 and G3 (OU) and G2 and G3
(OU)
Groups
N
CT IHNL %
CT IHALT %
p value
G1 OU
5
100.00
0.00
1
G3 OU
7
85.71
14.29
G2 OU
6
100.00
0.00
1
G3 OS
7
85.71
14.29
table_chartTable 5
Farnsworth D-15 AO color test: comparison between groups G1 and G2
Groups
N
CT FW-D15 NL %
CT FW-D15 ALT %
p value
G1 OU
5
20.00
80.00
0.206
G2 OU
4
75.00
25.00
G1 OU
5
20.00
80.00
0.524
G3 OU
4
50.00
50.00
G2 OU
4
75.00
25.00
1
G3 OU
4
50.00
50.00
table_chartTable 6
Strabismus: Comparison between premature infants after ROP treatment (G1) and
after remission of ROP Stages II and III (G2)
Groups
N
Strabismus Yes (%)
Strabismus No (%)
p value
G1 OU
7
0.00
100.00
0.200
G2 OU
8
37.50
62.50
G1 OU
7
0.00
100.00
-
G3 OU
9
0.00
100.00
G2 OU
8
37.50
62.50
0.082
G3 OU
9
0.00
100.00
table_chartTable 7
Stereopsis: Comparison between premature infants with after treatment RO (G1)
and after remission of ROP Stages II and III (G2)
Groups
N
Stereopsis NL (%)
Stereopsis ALT (%)
p value
G1 OU
7
0.00
100.00
p: 0.467
G2 OU
8
25.00
75.00
G1 OU
7
0.00
100.00
p: 0.200
G3 OU**
= one premature infant did not undergo the Titmus test.
8
37.50
62.50
G2 OU
8
25.00
75.00
P:1
G3 OU
8
37.50
62.50
table_chartChart 1
Demographic data for the three groups of premature preschool children
classified into three groups of retinopathy of prematurity (G1, G2, and G3),
considering the variables gender, chronological age on re-evaluation (CRA),
gestational age (GA), birth weight (BW), and number of medical consultations
between the selection and re-evaluation periods
Groups
Gender
CRA (years)
GA (weeks)
WB (grams)
Number of Visits
N
M (%)
F (%)
mean
DP
mean
DP
mean
DP
mean
DP
G 1
7
71
29
6.1
1.6
28.1
1.9
1.015
123.5
24.4
20.5
G 2
8
25
75
6.5
1.9
27.2
1.6
963.7
123.0
19.8
13.9
G 3
9
78
22
5.1
0.9
28.4
2.5
991.1
258.4
9.7
4.2
table_chartChart 2
Distribution of static refraction and vA data in groups G1, G2, and G3
Right eye
Left eye
Spherical
Cylinder
Axis
Acuity
Spherical
Cylinder
Axis
Acuity
G1- laser
1
+0.50
-0.50
180
20/20
0.00
-0.50
180
20/20
2
+2.00
0.00
0
20/20
+1.50
0.00
0
20/30
3
-5.50
-3.00
105
20/30
-4.25
0.00
0
20/25
4
-4.25
-0.75
125
20/60
0.00
0.00
0
20/20
5
+0.50
-1.75
180
20/30
-0.50
-3.00
180
20/40
6
-6.50
-2.00
170
20/30
**
= refraction impossible, total retinal detachment;
****
= amaurosis.
7
-2.75
-0.50
180
20/63
-2.75
-0.50
180
20/63
G2- without laser
8
+4.50
-1.25
10
20/20
+4.75
-1.50
170
20/20
9
+2.25
0.00
0
20/20
+2.50
0.00
0
20/20
10
+2.00
-0.50
165
20/20
+2.25
0.00
0
20/20
11
+2.00
-0.50
180
20/20
+2.00
-0.50
165
20/20
12
+0.25
-0.25
90
20/20
+0.25
0.00
0
20/20
13
+1.50
-0.25
90
20/20
+1.50
-0.25
5
20/20
14
+1.75
-1.25
15
20/50
+1.75
-1.50
180
20/50
15
+2.00
-0.50
90
20/20
+1.50
0.00
0
20/20
G3- without ROP
16
-0.25
0.00
0
20/20
0.00
0.00
0
20/20
17
+2.50
0.00
0
20/20
+2.50
0.00
0
20/20
18
+1.50
-0.75
180
20/20
+1.50
-1.00
180
20/20
19
+1.00
-0.50
180
20/20
+1.00
-0.50
180
20/20
20
+1.75
0.00
0
20/20
+2.00
-0.50
180
20/20
21
+3.00
-0.25
90
20/20
+2.50
0.00
0
20/20
22
+1.50
0.00
0
20/20
+1.50
-0.50
90
20/20
23
+1.00
0.00
0
20/20
+1.00
0.00
0
20/20
24
+1.25
-0.50
170
20/20
+1.50
0.00
0
20/20
Como citar
Bonotto, Lígia Beatriz et al. Estudo comparativo das funções visuais em pré-escolares nascidos prematuros com e sem retinopatia da prematuridade. Arquivos Brasileiros de Oftalmologia [online]. 2014, v. 77, n. 1 [Acessado 9 Abril 2025], pp. 34-39. Disponível em: <https://doi.org/10.5935/0004-2749.20140010>. ISSN 1678-2925. https://doi.org/10.5935/0004-2749.20140010.
Conselho Brasileiro de OftalmologiaRua Casa do Ator, 1117 - cj.21, 04546-004 São Paulo SP Brazil, Tel: 55 11 - 3266-4000, Fax: 55 11- 3171-0953 -
São Paulo -
SP -
Brazil E-mail: abo@cbo.com.br
rss_feed
Acompanhe os números deste periódico no seu leitor de RSS
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.